PI3K Antagonist
-
ST-162
0 ImagesArt. -Nr.: HY-124615CAS. Nr.: 1883817-83-1ST-162 is a MAPK/PI3K dual antagonist. ST-162 exhibits antitumor activity and can increase the efficacy of immune checkpoint blockers. ST-162 can be used for the research of cancer, such as melanoma.
